Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucose and Lipid Metabolism”

1,508 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,508 results

Not applicableStudy completedNCT00720889
What this trial is testing

Glucose Metabolism and Sleep in People With Family History of Type 2 Diabetes.

Who this might be right for
SleepInsulin ResistanceType 2 Diabetes
University of Chicago 20
Not applicableLooking for participantsNCT05564273
What this trial is testing

Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions

Who this might be right for
Metabolic Health
Viome 150
Not applicableUnknownNCT03047668
What this trial is testing

POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNAFLDObesity+3 more
German Institute of Human Nutrition 200
Not applicableActive Not RecruitingNCT06405880
What this trial is testing

Pharmacist Case Finding and Intervention for Vascular Prevention Trial

Who this might be right for
Cardiovascular Risk FactorsBlood PressureCardiovascular Disease+2 more
University of Alberta 1,003
Early research (Phase 1)Study completedNCT04142424
What this trial is testing

Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Who this might be right for
Metabolic DisordersNon-alcoholic Steatohepatitis
AstraZeneca 73
Not applicableUnknownNCT05887180
What this trial is testing

PräVaNet - Structured, Intersectoral, Multiprofessional, Digitized Program to Optimize Cardiovascular Prevention

Who this might be right for
Type 2 DiabetesArteriosclerosisArterial Hypertension+1 more
Charite University, Berlin, Germany 209
Testing effectiveness (Phase 2)Study completedNCT01531569
What this trial is testing

Single Oral Dose of BeneFlax to Healthy Young and Older Adults

Who this might be right for
Diabetes Mellitus, Type 2Hypercholesterolemia
University of Saskatchewan 22
Large-scale testing (Phase 3)Study completedNCT00240305
What this trial is testing

Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

Who this might be right for
Metabolic SyndromeDyslipidemia
AstraZeneca 15
Not applicableUnknownNCT01658137
What this trial is testing

Diet Intervention and GEnetic STudy (DIGEST-Pilot)

Who this might be right for
Cardiovascular DiseasesInflammationDyslipidemias+2 more
McMaster University 84
Post-approval studies (Phase 4)UnknownNCT02035644
What this trial is testing

Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)

Who this might be right for
Type 2 DiabetesDyslipidemia
Shanghai Jiao Tong University School of Medicine 360
Not applicableStudy completedNCT00046267
What this trial is testing

Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients

Who this might be right for
HIV InfectionsHypercholesterolemiaHypertriglyceridemia+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT02726100
What this trial is testing

SMARTHealth Diabetes in China Using Lay Family Health Promoters

Who this might be right for
Diabetes Mellitus, Type 2HypertensionDyslipidemias
The George Institute for Global Health, China 2,073
Not applicableStudy completedNCT02982408
What this trial is testing

Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusInsulin ResistanceDyslipidemia
Rigshospitalet, Denmark 48
Testing effectiveness (Phase 2)Study completedNCT00400231
What this trial is testing

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

Who this might be right for
Metabolic Syndrome x
University of Pennsylvania 124
Not applicableStudy completedNCT03526445
What this trial is testing

Hepatic Metabolic Changes in Response to Glucagon Infusion

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseTotal PancreatectomyDiabetes Mellitus
Steno Diabetes Center Copenhagen 27
Post-approval studies (Phase 4)Study completedNCT03299153
What this trial is testing

The Effects of Barberry Juice Consumption in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
National Nutrition and Food Technology Institute 46
Not applicableStudy completedNCT02490553
What this trial is testing

Epidemiological Study on the Relationship Between Respiratory Health and Air Pollution From Industrial Sources

Who this might be right for
Airway ObstructionHypertensionDiabetes Mellitus+2 more
University Hospital, Lille 3,276
Testing effectiveness (Phase 2)Study completedNCT05042973
What this trial is testing

The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure

Who this might be right for
ObesityHeart Failure
Jacob Moller 165
Large-scale testing (Phase 3)Study completedNCT00308386
What this trial is testing

DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)

Who this might be right for
Diabetes MellitusHypertensionHyperlipidemia
Milton S. Hershey Medical Center 550
Post-approval studies (Phase 4)Study completedNCT00442325
What this trial is testing

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 595
Next Page